Investigating cardiovascular diseases related to endocrine therapy in hormone receptor-positive early breast cancer: insights from a nationwide real-world study
ETs may be associated with alterations in lipid metabolism and a potential increase in CVD risk in early-stage HR + BC patients. These findings highlight the relevance of enhanced lipid monitoring and cardiovascular risk management to support optimized treatment outcomes in the Chinese population.
Authors
- Lixi Li (ORCID: https://orcid.org/0000-0001-5790-5052)
- Fei Ma (ORCID: https://orcid.org/0000-0001-9432-1902)
- Jiani Wang (ORCID: https://orcid.org/0000-0002-0618-8337)
- Bo Lan (ORCID: https://orcid.org/0000-0002-6685-539X)
- Xiu‐Qing Li (ORCID: https://orcid.org/0000-0002-7308-0596)
- Wenjing Yang (ORCID: https://orcid.org/0009-0008-8722-2269)
- Binliang Liu (ORCID: https://orcid.org/0000-0002-3692-2272)
- Hong Li (ORCID: https://orcid.org/0000-0001-5195-4339)
- Wenna Wang (ORCID: https://orcid.org/0000-0003-3253-8617)
- Cheng Zeng (ORCID: https://orcid.org/0000-0002-9392-8259)
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- National Cancer Center (US)
- Hunan Cancer Hospital (CN)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1186/s40959-025-00333-6
- Citations
- 5
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 9.09
Funders
- China Medical Board
- National Science and Technology Major Project
- National Key Research and Development Program of China